Form 4 for ANVS Annovis Bio, Inc.
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-19 · accession 0001104659-25-080981 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-20 | 2025-08-19 | ANVS | Hoffman Michael B | Dir | A - Grant | $2.59 | +18.6K | 1.46M | +1% | +$48.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-19 | A | A | 5,545 | $2.58 | 1,463,829 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-19 | A | A | 5,283 | $2.59 | 1,458,284 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-19 | A | A | 6,717 | $2.60 | 1,453,001 | D | — | — | |
| 4 | Common | Common Stock | 2025-08-19 | A | A | 1,100 | $2.57 | 1,464,929 | D | — | — |